Trial NCT00539838

View at ClinicalTrials.gov 
Org. Study IDs: ACT4071g
Secondary IDs: WA20499

Last trial update was posted on 2020-09-17

MeSH Interventions

Azathioprine Immunosuppressive Agents Methotrexate Methylprednisolone Mycophenolic Acid Ocrelizumab Prednisone

MeSH Conditions

Lupus Erythematosus, Systemic

Other Conditions

Systemic Lupus Erythematosus

Stopping Reasons

The study was terminated prematurely when the decision was made that ocrelizumab was not likely to benefit this patient population.

Limitations And Caveats

The study was terminated before any patients reached the Week 48 visit. Therefore, the safety analysis included all safety data for the 33 randomized patients that were available up to the data cutoff date (22 March 2010)

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID